Loading…
Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine
Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hem...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2000-10, Vol.36 (4), p.642-647 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3 |
container_end_page | 647 |
container_issue | 4 |
container_start_page | 642 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 36 |
creator | Sánchez-Lozada, Laura G Gamba, Gerardo Bolio, Alexis Jiménez, Fabiola Herrera-Acosta, Jaime Bobadilla, Norma A |
description | Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects. |
doi_str_mv | 10.1161/01.HYP.36.4.642 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205301116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>62757796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</originalsourceid><addsrcrecordid>eNpFkNFv0zAQhy3ExMrgmTdkwXMyn31OnMepAjap6qZtSOPJsh2HeqRJZyeM_vd4agWWTvZJn39nf4R8AFYCVHDOoLz8cVOKqsSyQv6KLEByLFBW4jVZMGiwaAAeTsnblB4ZA0Ss35BTAIaMS1iQh3XofBt2YfD0JvrffpgSXW7M8NMnGga6DlMMjl7_Ca2nd_th2pjk6fZ2fUFXme4TvRra2fmW2j1d7l0_pt0Yc9o7ctKZPvn3x_2MfP_65X55Wayuv10tL1aFw1ryQnSV5QY5d2ihzc9TxlisbGcZOO9aUBZ5JTrktmmUUDUo1bC6clJ6aVUnzsinQ-4ujk-zT5N-HOc45JGaMykYZE8ZOj9ALo4pRd_pXQxbE_camH4RqRnoLFKLSqPOIvONj8fY2W59-58_msvA5yNgkjN9F83gQvrH1Y2sUWUKD9Tz2E8-pl_9_Oyj3njTTxvN8sq_UwXPB3jpilyCi79g4YkX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205301116</pqid></control><display><type>article</type><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><source>EZB Electronic Journals Library</source><creator>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</creator><creatorcontrib>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</creatorcontrib><description>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.36.4.642</identifier><identifier>PMID: 11040251</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Biological and medical sciences ; Body Weight - drug effects ; Cyclosporine - pharmacology ; Cyclosporine - toxicity ; Drug toxicity and drugs side effects treatment ; Glomerular Filtration Rate - drug effects ; Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism ; Isoenzymes - genetics ; Isoenzymes - metabolism ; Kidney Cortex - drug effects ; Kidney Cortex - enzymology ; Kidney Medulla - drug effects ; Kidney Medulla - enzymology ; Liver - drug effects ; Liver - enzymology ; Liver Function Tests ; Male ; Medical sciences ; Nephrectomy ; Nifedipine - pharmacology ; Nitric Oxide Synthase - drug effects ; Nitric Oxide Synthase - genetics ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type I ; Nitric Oxide Synthase Type II ; Nitric Oxide Synthase Type III ; Organ Specificity ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; RNA, Messenger - drug effects ; RNA, Messenger - metabolism ; Toxicity: urogenital system</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2000-10, Vol.36 (4), p.642-647</ispartof><rights>2000 American Heart Association, Inc.</rights><rights>2001 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Oct 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</citedby><cites>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=795748$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11040251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Lozada, Laura G</creatorcontrib><creatorcontrib>Gamba, Gerardo</creatorcontrib><creatorcontrib>Bolio, Alexis</creatorcontrib><creatorcontrib>Jiménez, Fabiola</creatorcontrib><creatorcontrib>Herrera-Acosta, Jaime</creatorcontrib><creatorcontrib>Bobadilla, Norma A</creatorcontrib><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cyclosporine - pharmacology</subject><subject>Cyclosporine - toxicity</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glomerular Filtration Rate - drug effects</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</subject><subject>Isoenzymes - genetics</subject><subject>Isoenzymes - metabolism</subject><subject>Kidney Cortex - drug effects</subject><subject>Kidney Cortex - enzymology</subject><subject>Kidney Medulla - drug effects</subject><subject>Kidney Medulla - enzymology</subject><subject>Liver - drug effects</subject><subject>Liver - enzymology</subject><subject>Liver Function Tests</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrectomy</subject><subject>Nifedipine - pharmacology</subject><subject>Nitric Oxide Synthase - drug effects</subject><subject>Nitric Oxide Synthase - genetics</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type I</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Organ Specificity</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>RNA, Messenger - drug effects</subject><subject>RNA, Messenger - metabolism</subject><subject>Toxicity: urogenital system</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpFkNFv0zAQhy3ExMrgmTdkwXMyn31OnMepAjap6qZtSOPJsh2HeqRJZyeM_vd4agWWTvZJn39nf4R8AFYCVHDOoLz8cVOKqsSyQv6KLEByLFBW4jVZMGiwaAAeTsnblB4ZA0Ss35BTAIaMS1iQh3XofBt2YfD0JvrffpgSXW7M8NMnGga6DlMMjl7_Ca2nd_th2pjk6fZ2fUFXme4TvRra2fmW2j1d7l0_pt0Yc9o7ctKZPvn3x_2MfP_65X55Wayuv10tL1aFw1ryQnSV5QY5d2ihzc9TxlisbGcZOO9aUBZ5JTrktmmUUDUo1bC6clJ6aVUnzsinQ-4ujk-zT5N-HOc45JGaMykYZE8ZOj9ALo4pRd_pXQxbE_camH4RqRnoLFKLSqPOIvONj8fY2W59-58_msvA5yNgkjN9F83gQvrH1Y2sUWUKD9Tz2E8-pl_9_Oyj3njTTxvN8sq_UwXPB3jpilyCi79g4YkX</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>Sánchez-Lozada, Laura G</creator><creator>Gamba, Gerardo</creator><creator>Bolio, Alexis</creator><creator>Jiménez, Fabiola</creator><creator>Herrera-Acosta, Jaime</creator><creator>Bobadilla, Norma A</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>200010</creationdate><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><author>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cyclosporine - pharmacology</topic><topic>Cyclosporine - toxicity</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glomerular Filtration Rate - drug effects</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</topic><topic>Isoenzymes - genetics</topic><topic>Isoenzymes - metabolism</topic><topic>Kidney Cortex - drug effects</topic><topic>Kidney Cortex - enzymology</topic><topic>Kidney Medulla - drug effects</topic><topic>Kidney Medulla - enzymology</topic><topic>Liver - drug effects</topic><topic>Liver - enzymology</topic><topic>Liver Function Tests</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrectomy</topic><topic>Nifedipine - pharmacology</topic><topic>Nitric Oxide Synthase - drug effects</topic><topic>Nitric Oxide Synthase - genetics</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type I</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Organ Specificity</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>RNA, Messenger - drug effects</topic><topic>RNA, Messenger - metabolism</topic><topic>Toxicity: urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Lozada, Laura G</creatorcontrib><creatorcontrib>Gamba, Gerardo</creatorcontrib><creatorcontrib>Bolio, Alexis</creatorcontrib><creatorcontrib>Jiménez, Fabiola</creatorcontrib><creatorcontrib>Herrera-Acosta, Jaime</creatorcontrib><creatorcontrib>Bobadilla, Norma A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Lozada, Laura G</au><au>Gamba, Gerardo</au><au>Bolio, Alexis</au><au>Jiménez, Fabiola</au><au>Herrera-Acosta, Jaime</au><au>Bobadilla, Norma A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2000-10</date><risdate>2000</risdate><volume>36</volume><issue>4</issue><spage>642</spage><epage>647</epage><pages>642-647</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>11040251</pmid><doi>10.1161/01.HYP.36.4.642</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2000-10, Vol.36 (4), p.642-647 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_journals_205301116 |
source | EZB Electronic Journals Library |
subjects | Animals Biological and medical sciences Body Weight - drug effects Cyclosporine - pharmacology Cyclosporine - toxicity Drug toxicity and drugs side effects treatment Glomerular Filtration Rate - drug effects Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism Isoenzymes - genetics Isoenzymes - metabolism Kidney Cortex - drug effects Kidney Cortex - enzymology Kidney Medulla - drug effects Kidney Medulla - enzymology Liver - drug effects Liver - enzymology Liver Function Tests Male Medical sciences Nephrectomy Nifedipine - pharmacology Nitric Oxide Synthase - drug effects Nitric Oxide Synthase - genetics Nitric Oxide Synthase - metabolism Nitric Oxide Synthase Type I Nitric Oxide Synthase Type II Nitric Oxide Synthase Type III Organ Specificity Pharmacology. Drug treatments Rats Rats, Wistar RNA, Messenger - drug effects RNA, Messenger - metabolism Toxicity: urogenital system |
title | Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A20%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nifedipine%20Prevents%20Changes%20in%20Nitric%20Oxide%20Synthase%20mRNA%20Levels%20Induced%20by%20Cyclosporine&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=S%C3%A1nchez-Lozada,%20Laura%20G&rft.date=2000-10&rft.volume=36&rft.issue=4&rft.spage=642&rft.epage=647&rft.pages=642-647&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.36.4.642&rft_dat=%3Cproquest_cross%3E62757796%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205301116&rft_id=info:pmid/11040251&rfr_iscdi=true |